Parkinson’s disease - Savikalpa Academy

There’s no notification yet!

Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial

Introduction: Parkinson’s disease (PD) has a progressive course and is characterized by the degeneration of dopaminergic neurons. Although no neuroprotective treatments for PD have been found to date, the endocannabinoid system has emerged as a promising target.

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series

What is known and objective: Cannabidiol (CBD) is the main non-psychotropic component of the Cannabis sativa plant. REM sleep behaviour disorder (RBD) is a parasomnia characterized by the loss of muscle atonia during REM sleep associated with nightmares and active behaviour during dreaming. We have described the effects of CBD in RBD symptoms in patients with Parkinson’s disease.

DISCLAIMER – All individuals accessing this site undertake full responsibility for their own assessment of the accuracy/relevance of any and all content found herein. The content found on this site is not intended to serve as a substitute for medical advice/diagnosis/treatment from a qualified and licensed health care provider. This information should also in no way be misconstrued as professional legal advice regarding legislative, regulatory or any other matters. Individuals should always seek out the guidance of fully qualified professionals.

Sign up for our Newsletter

MIGRAINE

INSOMNIA

HEADACHES

CANCER PAIN

ENDOMETRIOSIS

ARTHRITIS

PARKINSON'S

MULTIPLE SCLEROSIS

PSORIASIS

PELVIC PAIN

IBD

STRESS & ANXIETY

Sign up for our Newsletter

Filter